Can patient-led surveillance detect recurrent or new primary melanoma & reduce need for routinely scheduled follow-up? A Randomised Controlled Trial.

以患者为主导的监测能否检测复发或新发的原发性黑色素瘤

• 批准号: nhmrc : GNT1163054
• 金额: $ 122.92万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/patient-led-surveillance-controlled-trial/1379272
• 关键词: patient; led; surveillance; detect; recurrent

Melanoma survivors need lifelong skin checks for new melanomas and other skin cancers. Technology now provides smartphone Apps which guide patients’ own skin checking and allow photography of areas of possible concern. The results are sent for a dermatologist’s review, which may prompt a clinic visit for further investigation. However the effectiveness & safety of using new technologies for skin checks are unknown, and our trial seeks to generate the evidence needed to assess this.

黑色素瘤幸存者需要终身皮肤检查新的黑色素瘤和其他皮肤癌。现在的技术提供了智能手机应用程序，可以指导患者自己进行皮肤检查，并允许对可能关注的区域进行拍照。结果将被发送给皮肤科医生进行审查，这可能会促使他们去诊所进行进一步调查。然而，使用新技术进行皮肤检查的有效性和安全性尚不清楚，我们的试验旨在产生评估这一点所需的证据。